ArticleInternational journal of ophthalmology2026
Comparison of posterior scleral reinforcement surgery and repeated low-level red-light therapy in controlling high and super high myopia in Chinese children.
Article in International journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo compare the efficacy of posterior scleral reinforcement (PSR) surgery versus repeated low-level red light therapy (RLRL) treatment in controlling high and super high myopia (HM and SHM) of Chinese children.
methodsThis retrospective case analysis enrolled Chinese children with HM (-6.00 to -10.00 D; 76 children, 120 eyes) or SHM (<-10.00 D; 82 children, 114 eyes) according to spherical equivalent (SE). Each group was further subdivided into PSR subgroup [single-vision spectacle lenses (SVS) combined with PSR surgery], RLRL subgroup (SVS combined with RLRL therapy), and control subgroup (SVS alone). All participants were followed up at baseline, 3mo, 1, and 2y after treatment. The best corrected visual acuity (BCVA), axial length (AL), SE, and adverse reactions were evaluated.
resultsA total of 158 children (234 eyes) aged 6-16y were enrolled consecutively. Baseline BCVA, AL and SE were comparable among subgroups in both HM and SHM groups (all
conclusionPSR and RLRL effectively improve BCVA in children with HM and SHM. PSR slows AL and SE progression, whereas RLRL reduces AL and SE, with better BCVA and AL outcomes in SHM at 1 and 2y. Both interventions are safe without severe adverse events within 2y. As a non-surgical approach, RLRL has promising clinical value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.